Table 1.
Expression of NOD1 in CINs and ISCCs
Tissues | Degree of immunoreactivity(%) | |||
---|---|---|---|---|
– | 1+ | 2+ | 3+ | |
Normala | 1/36 (2.8) | 7/36 (19.4) | 15/36 (41.7) | 13/36 (36.1) |
CIN Ib | 7/50 (14.0) | 28/50 (56.0) | 14/50 (28.0) | 1/50 (2.0) |
CIN IIc | 25/52 (48.1) | 22/52 (42.3) | 5/52 (9.6) | 0/52 (0.0) |
CIN IIId | 25/44 (56.8) | 16/44 (36.4) | 3/44 (6.8) | 0/44 (0.0) |
ISCCse | 52/61 (85.2) | 9/61 (14.8) | 0/61 (0.0) | 0/61 (0.0) |
CIN cervical intraepithelial neoplasia, ISCCs invasive squamous cell carcinomas
a-bP < 0.005, a-cP < 0.005, a-dP < 0.005, a-eP < 0.005, b-cP < 0.005, b-dP < 0.005,
b-eP < 0.005, c-dP > 0.05, c-eP < 0.005, d-eP < 0.05;